CSF interocular interactions in childhood ambylopia

Functional consequences of amblyopia and its impact on health-related quality of life

Amblyopia (lazy eye) is the most common cause of monocular vision loss, affecting up to 4% of children and often persisting into adulthood. While treating the visual acuity deficit is often the focus of treatment, there is a pressing need for researchers, educators, and clinicians to understand the effects of amblyopia that extend beyond visual acuity. This review article highlights recent advances in understanding the impact of amblyopia on everyday life functioning. Amblyopia can significantly interfere with contrast sensitivity, attention, reading, eye-hand coordination, body composition, physical activity, and health-related quality of life. A deeper understanding of the functional consequences of amblyopia can be applied to patient management and inform amblyopia treatment, as well as support research into more effective interventions to prevent or rehabilitate deficits that can hinder children's physical, social, and academic success.

Contrast Sensitivity in Microtropic and Anisometropic Eyes of Successfully Treated Amblyopes

Objectives:

To assess and compare contrast sensitivity function in the previously amblyopic and non-amblyopic “normal” eyes of patients with microtropia and anisometropia who achieved 20/20 visual acuity after occlusion therapy.

Materials and Methods:

Contrast sensitivity was tested monocularly on both eyes of 34 successfully treated microtropic and 15 anisometropic subjects (visual acuity 20/20 in both eyes). Contrast sensitivity function was evaluated by CSV-1000E and age-matched nomograms were used (spatial frequencies of 3, 6, 12, and 18 cycles per degree [cpd]) for comparison.

Results:

The mean age of subjects was 11.2±1.3 years in the microtropic group, 9.8±1.7 years in the anisometropic group (7-12 years); the mean follow-up time was 16.4±3.2 months (12 to 92) in the microtropic group and 27.7±1.8 months (12-84) in the anisometropic group. Statistical comparison of the microtropic amblyopic eyes versus non-microtropic eyes showed significant differences at spatial frequencies of 3, 12 and 18 cpd (3 cpd, t=2.8, p=0.007; 6 cpd, t=1.1 p=0.261; 12 cpd, t=2.2, p=0.033; 18 cpd, t=2.2, p=0.030). When anisometropic eyes were compared with non-anisometropic eyes, there was a significant difference only at 12 cpd (t=2.1 p=0.049). The comparison of non-amblyopic eyes versus age-matched nomograms revealed no differences at any of the spatial frequencies (p>0.05 for all).

Conclusion:

Contrast sensitivity was decreased in patients with amblyopia, especially in the microtropic group. The assessment of contrast sensitivity function may serve as a new parameter for termination of occlusion therapy.

Global motion perception in children with amblyopia as a function of spatial and temporal stimulus parameters

Global motion sensitivity in typically developing children depends on the spatial (Δx) and temporal (Δt) displacement parameters of the motion stimulus. Specifically, sensitivity for small Δx values matures at a later age, suggesting it may be the most vulnerable to damage by amblyopia. To explore this possibility, we compared motion coherence thresholds of children with amblyopia (7-14years old) to age-matched controls. Three Δx values were used with two Δt values, yielding six conditions covering a range of speeds (0.3-30deg/s). We predicted children with amblyopia would show normal coherence thresholds for the same parameters on which 5-year-olds previously demonstrated mature performance, and elevated coherence thresholds for parameters on which 5-year-olds demonstrated immaturities. Consistent with this, we found that children with amblyopia showed deficits with amblyopic eye viewing compared to controls for small and medium Δx values, regardless of Δt value. The fellow eye showed similar results at the smaller Δt. These results confirm that global motion perception in children with amblyopia is particularly deficient at the finer spatial scales that typically mature later in development. An additional implication is that carefully designed stimuli that are adequately sensitive must be used to assess global motion function in developmental disorders. Stimulus parameters for which performance matures early in life may not reveal global motion perception deficits.

Pharmacological enhancement of treatment for amblyopia

Background

The purpose of this study was to compare a weight-adjusted dose of carbidopa- levodopa as treatment adjunctive to occlusion therapy with occlusion therapy alone in children and adults with different types of amblyopia.

Methods

This prospective study included 63 patients with amblyopia classified into two groups, ie, an occlusion group which included 35 patients who received occlusion therapy only and a pharmacological enhancement group which included 28 patients who received oral carbidopa-levodopa together with occlusion therapy for 6 weeks.

Results

The mean logarithm of the minimal angle of resolution (logMAR) of the eyes with amblyopia was not significantly different in the occlusion group (0.52, 0.52, and 0.51) than in the pharmacological enhancement group (0.58, 0.49, and 0.56) at three follow-up visits (at months 1, 3, and 12, respectively). There was a highly significant improvement in mean logMAR of amblyopic eyes compared with baseline in both occlusion groups (from 0.68 to 0.52, from 0.68 to 0.52, and from 0.68 to 0.51) and in the pharmacological enhancement group (from 0.81 to 0.58, from 0.81 to 0.49, and from 0.81 to 0.56) at the month 1, 3, and 12 visits (P = 0.01, P = 0.01, and P = 0.001, respectively). The improvement of mean logMAR in the subgroup of patients older than 12 years was greater in the pharmacological enhancement group (42.5%) than in the occlusion group (30%). The improvement of mean logMAR in the subgroup of patients with severe amblyopia was greater in the pharmacological enhancement group (34.3%) than in the occlusion group (22%).

Conclusion

Significant improvement was reported in both groups at all follow-up visits over 1 year. Regardless of the etiology of amblyopia, levodopa-carbidopa may be added to part-time occlusion in older patients as a means of increasing the plasticity of the visual cortex. Levodopa may add to the effect of occlusion in severe amblyopia and bilateral amblyopia.

Visual acuity deficits in the fellow eyes of children with unilateral amblyopia

PURPOSE

To study the visual acuity deficits and maturation in the fellow eyes of children with unilateral amblyopia who were treated with patching.

METHODS

Medical records of patients aged 4-13 years visiting a tertiary eye care center between January 2003 and December 2007 who were diagnosed for the first time with unilateral amblyopia were reviewed. Subjects included in the study were followed through April 2009. The baseline visual acuity in the fellow eye of amblyopic subjects was compared with that of age-matched healthy subjects. Changes in visual acuity in the amblyopic and fellow eyes during subsequent visits were analyzed.

RESULTS

A total of 112 children with amblyopia were included (strabismic, 14; anisometropic, 51; combined mechanism, 47). Baseline visual acuity in the fellow eye of these children differed significantly from that of age-matched controls up to 8 years of age. Average logMAR acuity reached 0.0 at age 5 years in controls versus age 9 years in patients. Although the mean visual acuity of the fellow eyes improved during treatment, 21% developed temporary occlusion amblyopia. Full-time patching had no additional benefit when compared with part-time patching.

CONCLUSIONS

Visual acuity in the fellow eye of children with unilateral amblyopia is reduced at baseline and matures more slowly than in healthy control patients. The risk for temporary occlusion amblyopia in the fellow eye is similar what has been previously reported.

Amblyopia: a mini review of the literature

Amblyopia is a form of cerebral visual impairment in the absence of an organic cause. It is considered to derive from the degradation of the retinal image associated with abnormal visual experience during the developmental period of the visual system in infancy and early childhood. Amblyopia is a significant cause of unilateral visual deficit in childhood and is still considered as one of the most common causes of persistent unilateral visual impairment in adulthood. The following review aims at presenting the contemporary literature regarding the prevalence, the aetiology, the neural correlates, the period of critical development, the treatment, the prognosis and the disability associated with this visual deficit.

Eye-hand coordination skills in children with and without amblyopia

PURPOSE

To investigate whether binocular information provides benefits for programming and guidance of reach-to-grasp movements in normal children and whether these eye-hand coordination skills are impaired in children with amblyopia and abnormal binocularity.

METHODS

Reach-to-grasp performance of the preferred hand in binocular versus monocular (dominant or nondominant eye occluded) conditions to different objects (two sizes, three locations, and two to three repetitions) was quantified by using a 3D motion-capture system. The participants were 36 children (age, 5-11 years) and 11 adults who were normally sighted and 21 children (age, 4-8 years) who had strabismus and/or anisometropia. Movement kinematics and error rates were compared for each viewing condition within and between subject groups.

RESULTS

The youngest control subjects used a mainly programmed (ballistic) strategy and collided with the objects more often when viewing with only one eye, while older children progressively incorporated visual feedback to guide their reach and, eventually, their grasp, resulting in binocular advantages for both movement components resembling those of adult performance. Amblyopic children were the worst performers under all viewing conditions, even when using the dominant eye. They spent almost twice as long in the final approach to the objects and made many (1.5-3 times) more errors in reach direction and grip positioning than their normal counterparts, these impairments being most marked in those with the poorest binocularity, regardless of the severity or cause of their amblyopia.

CONCLUSIONS

The importance of binocular vision for eye-hand coordination normally increases with age and use of online movement guidance. Restoring binocularity in children with amblyopia may improve their poor hand action control.

Comparison of the visual effects of Fresnel prisms in normal and amblyopic eyes

PURPOSE

To assess the effects of Fresnel prisms on visual acuity and peak contrast sensitivity in the amblyopic and sound eyes of participants with amblyopia and to determine whether these functions were affected by Fresnel prisms to a different degree than those of controls.

METHODS

The LogMAR visual acuity and peak contrast sensitivity of 10 unilateral amblyopic participants (mean age, 22.6 years) and 9 controls (mean age, 26.2 years) were tested with Fresnel prisms of powers 5(Delta), 10(Delta), 15(Delta), 20(Delta), and 25(Delta) and without a Fresnel prism.

RESULTS

A statistically significant reduction in visual acuity with increasing prism power was found for all 3 groups, with the visual acuity of the amblyopic eyes being the least affected by the prisms. No statistically significant differences were found between the control and the sound eyes. No statistically significant differences in the effects of the prisms on peak contrast sensitivity could be detected between the 3 groups. Fresnel prisms were found to have a smaller effect on those amblyopic eyes with a poorer baseline visual acuity, indicating that these eyes may tolerate strong prisms without substantially impairing their visual acuity.

CONCLUSIONS

Fresnel prisms have a lesser effect on the visual acuity of amblyopic eyes than on controls. In contrast, results for peak contrast sensitivity were very similar for each of the groups tested, and no significant differences were evident between the amblyopic, sound, and control eyes.

Amblyopia characterization, treatment, and prophylaxis

Amblyopia has a 1.6-3.6% prevalence, higher in the medically underserved. It is more complex than simply visual acuity loss and the better eye has sub-clinical deficits. Functional limitations appear more extensive and loss of vision in the better eye of amblyopes more prevalent than previously thought. Amblyopia screening and treatment are efficacious, but cost-effectiveness concerns remain. Refractive correction alone may successfully treat anisometropic amblyopia and it, minimal occlusion, and/or catecholamine treatment can provide initial vision improvement that may improve compliance with subsequent long-duration treatment. Atropine penalization appears as effective as occlusion for moderate amblyopia, with limited-day penalization as effective as full-time. Cytidin-5'-diphosphocholine may hold promise as a medical treatment. Interpretation of much of the amblyopia literature is made difficult by: inaccurate visual acuity measurement at initial visit, lack of adequate refractive correction prior to and during treatment, and lack of long-term follow-up results. Successful treatment can be achieved in at most 63-83% of patients. Treatment outcome is a function of initial visual acuity and type of amblyopia, and a reciprocal product of treatment efficacy, duration, and compliance. Age at treatment onset is not predictive of outcome in many studies but detection under versus over 2-3 years of age may be. Multiple screenings prior to that age, and prompt treatment, reduce prevalence. Would a single early cycloplegic photoscreening be as, or more, successful at detection or prediction than the multiple screenings, and more cost-effective? Penalization and occlusion have minimal incidence of reverse amblyopia and/or side-effects, no significant influence on emmetropization, and no consistent effect on sign or size of post-treatment changes in strabismic deviation. There may be a physiologic basis for better age-indifferent outcome than tapped by current treatment methodologies. Infant refractive correction substantially reduces accommodative esotropia and amblyopia incidence without interference with emmetropization. Compensatory prism, alone or post-operatively, and/or minus lens treatment, and/or wide-field fusional amplitude training, may reduce risk of early onset esotropia. Multivariate screening using continuous-scale measurements may be more effective than traditional single-test dichotomous pass/fail measures. Pigmentation may be one parameter because Caucasians are at higher risk for esotropia than non-whites.

Clinical colour vision tests

The structure and function of the available and significant clinical colour vision tests are reviewed in the light of the needs in the clinical examination of congenital and acquired colour vision deficiencies. The tests are grouped and described as pseudo-isochromatic plates, arrangement tests, matching tests and vocational tests. The colorimetric constructions of the test types are described and the efficiency of their performance and usefulness discussed. Recommendations are made for basic and extended test batteries, when examining of congenital and acquired colour vision deficiencies in the consulting room.

Defining and measuring treatment outcome in unilateral amblyopia

AIM

To offer a critique of current methods of defining amblyopia treatment outcome and to examine alternative approaches.

METHOD

Literature appraisal and descriptive case presentations.

RESULTS

Currently, the outcome of amblyopia treatment is expressed as the number of acuity chart lines gained or, alternatively, achievement of an arbitrarily adopted level of visual acuity. As binocular vision is optimised with equal visual input from each eye the authors propose that the optimum outcome of amblyopia therapy is to achieve a visual acuity in the amblyopic eye equal to that of its fellow. In addition, improvement should be graded as the proportion of change in visual acuity with respect to the absolute potential for improvement (that is, that pertaining in the fellow eye at end of treatment).

CONCLUSIONS

There are two methods of appropriately describing the outcome of amblyopia treatment: firstly, by the difference in final visual acuity of amblyopic and fellow eye (residual amblyopia); secondly, the proportion of the deficit corrected.

Impact of interocular differences in corneal asphericity on binocular summation

PURPOSE

To evaluate the impact that interocular differences in corneal asphericity (Q) exert on binocular summation measured as the contrast-sensitivity function.

DESIGN

Interventional case series.

METHODS

A total of 92 emmetropic subjects took part in the experiment, classified according to the interocular differences in corneal asphericity (deltaQ) measured with an EyeSys-2000 corneal topographer. Fifty-four subjects had deltaQ < 0.1; 21 subjects had 0.1 < or = deltaQ < or = 0.2; and 17 had deltaQ > 0.2. The contrast-sensitivity function (CSF) was measured monocularly (for each eye) and binocularly with a B VAT II device. The spatial frequencies used were as follows: 2.4, 3.7, 6.0, 9.2, 12, 15, 20, and 24 cycles per degree.

RESULTS

Although the binocular CSF for the three groups studied was greater than the monocular in all the spatial frequencies studied, there were significant differences in binocular summation. The average binocular summation (for all the spatial frequencies) for the group with deltaQ < 0.1 was 1.46, significantly higher than the group with 0.1 < or = deltaQ < or = 0.2, in which the average binocular summation was 1.39 (P = .035), which was also significantly higher than the group deltaQ > 0.2, for which the average binocular summation was 1.26 (P < .0001). In this last group, the summation decreased to the level of the probability summation.

CONCLUSIONS

Differences in corneal asphericity may affect the binocular visual function by diminishing the binocular contrast-sensitivity function. This result may have important implications in refractive surgery given that, although the subject becomes emmetropic, if interocular differences are induced in corneal asphericity, it could reduce binocular visual performance.

Improving the effectiveness of the infant contrast sensitivity card procedure

Based on results from an earlier prototype, custom software and printing techniques were developed to construct a new card-based test of contrast sensitivity (CS) for nonverbal subjects. Compared with the prototype, the new CS card test contains three improvements: (1) larger, more salient test gratings; (2) higher contrast warm-up cards for each spatial frequency set; and (3) smaller contrast step size between adjacent cards. The success of the new cards was evaluated by testing 3.5- and 12-month-old human infants. Results indicated that the new version of the test required little time to complete (mean, 6.5 min) and provided accurate estimates of visual acuity. Also, group contrast sensitivity functions (CSFs) showed substantial development from 3.5 to 12 months of age. Surprisingly, however, group CSFs obtained with the new cards were lower than those obtained with the prototype, a discrepancy that may be due to differences in space average luminance between the two sets of cards. In all, the new CS card procedure possesses several merits that give it potential as an option for assessing spatial vision in infants, toddlers, and subjects with multiple impairments.

Effect of late surgery for acquired esotropia on visual evoked potential

PURPOSE

To asses the effect of strabismus surgery on visual evoked potential (VEP) amplitude after age 5 years in children with acquired esotropia.

METHODS

Visual evoked potentials to binocular and monocular pattern reversal stimulation were recorded in 10 children aged 5 to 6 years before and 3 months after surgical correction of their esotropia. Visual function (fusion) was tested by synoptophore after strabismus surgery. Electrophysiological and clinical data were correlated following surgical intervention.

RESULTS

A significant increase in pattern VEP amplitudes was noted following strabismus surgery. Visual evoked potential changes were most prominent on binocular stimulation. Binocular fusion showed similarly significant improvement after intervention. Postoperative VEP data, however, were not consistently correlated with functional improvement.

CONCLUSION

Surgical intervention in esotropia, even if performed years beyond the end of the classical critical period, can have a strong effect on binocular VEPs and a beneficial effect on the development of binocular fusion.

Strabismic amblyopia. Part 1. Psychophysics

This is a two-part survey of current literature concerning strabismic amblyopia. The aim of this review is to bring the optometric practitioner up to date on the status of scientific research into strabismic amblyopia. Part 1 in this series discusses research into strabismic amblyopia from the viewpoint of psychophysical experiments that investigate both spatial and temporal behavioural deficits accompanying strabismic amblyopia. These include deficits in contrast sensitivity, spatial localisation, fixation, ocular motility, accommodation, crowding, attention, motion perception and temporal processing. Part 2 will evaluate neural processing in regard to strabismic amblyopia. It will discuss current understanding of aspects of central processing of visual information and theories regarding neural sites and mechanisms involved in amblyopia.

Occlusion and levodopa-carbidopa treatment for childhood amblyopia

PURPOSE

The purpose of the current study was to compare the effects of levodopa-carbidopa with and without part-time occlusion on visual function in older amblyopic children.

METHODS

Thirteen older amblyopic children were randomly assigned to receive or not receive part-time occlusion (3 h/day) combined with 7 weeks of oral dosing with levodopa-carbidopa (1.02 mg/0.25 mg/kg body weight three times daily). Visual acuity, contrast sensitivity, and fusion were measured at baseline; 1, 3, 5, and 7 weeks during the treatment regimen; and 4 weeks after termination of all treatment. At these same times health status was assessed with standard laboratory blood tests, physical examination, and subjective questionnaire.

RESULTS

From baseline to the follow-up test trial, both groups improved in visual acuity in the amblyopic eyes (occlusion group 20/116 to 20/76, P < .001; no occlusion group 20/90 to 20/73, P < .01) and dominant eyes (occlusion group 20/18 to 20/15, P > .05; no occlusion group 20/20 to 20/16, P < .01). The occlusion group exhibited a significant decrease in the difference in acuity between the dominant and amblyopic eyes of 1.3 lines (P < .02), whereas the no occlusion group revealed no significant effect. A comparison between groups revealed a significantly greater improvement in visual acuity in the amblyopic eye in the occlusion group compared with the no occlusion group (P = .01). In contrast, there was no significant difference between groups in terms of the change in visual acuity in the dominant eye (P = .15). Mean log contrast sensitivity in the amblyopic eye significantly improved in the occlusion group and did not significantly change in the no occlusion group. Fusion changed similarly in both groups. The improvements in visual function were maintained 4 weeks after the termination of all treatment. Adverse side effects were minimal in both groups.

CONCLUSION

The combination of levodopa-carbidopa and occlusion improves visual function more than levodopa-carbidopa alone in older amblyopic children.

Movement hyperacuity in childhood amblyopia

BACKGROUND

Amblyopia results in deficits in a number of visual functions in both the amblyopic and dominant eye. The present work describes oscillatory movement displacement thresholds (OMDT) in childhood amblyopia.

METHODS

The OMDT from the dominant and amblyopic eyes of 50 orthoptic patients (aged 74 (SD 16) months) were compared with those from a group of 24 controls (79 (21) months). OMDT were measured using a forced choice staircase procedure. Subjects were asked to identify which of the computer controlled monitors displayed the oscillating stimulus. Visual acuity and stereoscopic responses were noted from clinical records.

RESULTS

Amblyopic children demonstrating stereopsis showed no significant OMDT deficit in the amblyopic eye. Those children having no stereopsis had elevated OMDT in the amblyopic eye (p < 0.05). Results suggest that the dominant eye of children with amblyopia may also have a pattern of visual development which is anomalous (difference in correlation coefficient with age; p < 0.05).

CONCLUSION

OMDT deficits demonstrated in some amblyopic eyes indicate that amblyopia is incompletely described by its "clinical" definition. Results suggest that the dominant eye in those with unilateral amblyopia may not be "normal".

Effectiveness of occlusion therapy in ametropic amblyopia: a pilot study

AIMS/BACKGROUND

To examine the relative contributions of non-specific (for example, spectacle correction) and specific (that is, occlusion therapy) treatment effects on children with ametropic amblyopia. To assess the importance and practicality of objectively confirming the prescribed occlusion dose.

METHODS

Subjects were entered into a two phase trial. In the first ('pretreatment') subjects were provided with spectacle correction and underwent repeat visual acuity (VA) and contrast sensitivity (CS) testing until acuity in their amblyopic eye had stabilised. Subjects then progressed to the second phase ('treatment') in which they underwent direct, unilateral occlusion for 1 hour per day for 4 weeks. Patching was objectively monitored using an occlusion dose monitor.

RESULTS

Eight subjects completed the trial, all but one of whom achieved > 80% concordance with the occlusion regimen. Within the pretreatment phase, mean amblyopic eye VA improved by 0.19 log units (p = 0.008) while mean CS gained 0.09 log units (p = 0.01). An identical improvement in mean VA was recorded in the fellow eyes (p = 0.03) while mean CS gained 0.11 log units (p = 0.02). Within the treatment phase, mean VA further improved (0.12 log units, p = 0.009) although this gain had halved by the end of treatment and was no longer statistically significant (p = 0.09).

CONCLUSIONS

Visual performance improved significantly during pretreatment whereas further gains seen during occlusion were not sustained. Evaluation of occlusion regimens must take into consideration the potentially confounding influence of 'pretreatment effects' and the necessity to confirm objectively the occlusion dose a child receives.

Unifying concepts in mechanism of amblyopia

Most of the evidence of formation of amblyopia is derived traditionally from electrophysiological studies. Recently, there have been many discoveries from genetics, histopathology, biochemistry, immunology and interventional studies. On the basis of evidence gathered in the last five years, the various types of amblyopia (strabismic and non-strabismic amblyopia) can be seen not only as disturbance of the development of the visual system at different points but as basically different pathologic processes. It is postulated here that strabismic amblyopia is initiated as a maladaptive differentiation in the ocular dominance columns, whereas the non-strabismic amblyopia may be initiated from the ganglion cell population of the amblyopic eye. The total clinical picture is confusing because of secondary changes in other parts of the central nervous system. The manifested features can be due to a slower, more enduring type of change (pooling, loss and re-wiring of the neurones) as well as a more transient, adaptive type of response (such as suppression of diplopia). Neurotransmitter replacement has a potential therapeutic application.

SKILL card results in amblyopic children

Two experiments were undertaken to assess high contrast-high luminance (HCHL) and low contrast-low luminance (LCLL) visual acuity as measured with the Smith-Kettlewell Institute Low Luminance (SKILL) card, in childhood amblyopia. In experiment 1, HCHL and LCLL visual acuity was measured in 11 amblyopic children and in 12 normal children of similar age. The results revealed that HCHL visual acuity was similar in the normal eyes and in the amblyopes' dominant eyes, and was abnormal in 91% of the amblyopic eyes. LCLL visual acuity was significantly worse in normal eyes compared to the amblyopes' dominant eyes, and was abnormal in only 64% of the amblyopic eyes. In experiment 2, HCHL and LCLL visual acuity was measured in seven previously tested amblyopic children, after a 5-month interval, and in six additional amblyopic children. In the amblyopic children who were tested twice, significant test-retest reliability for HCHL and LCLL visual acuity was found and visual acuity varied by 3.6%. The results of experiment 2 corroborated the results of experiment 1 from the amblyopic children. It is concluded that visual acuity in the amblyopic eye tends to normalize under low contrast-low luminance conditions. In addition, the mechanism(s) underlying amblyopia appear also to influence the dominant eye, resulting in superior visual acuity under low contrast-low luminance conditions.

Longitudinal study of levodopa/carbidopa for childhood amblyopia

To determine the tolerability and efficacy of levodopa/carbidopa combined with occlusion therapy for childhood amblyopia, a double-masked placebo-controlled randomized longitudinal study was performed on 10 amblyopic children between 6 and 14 years of age. Subjects received, on average, 20/5 mg levodopa/carbidopa or 20 mg of placebo three times per day combined with part-time occlusion over a 3-week period. Visual function was assessed by Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity charts and by contrast sensitivity. Tolerability was assessed by questionnaire, SMAC (standard laboratory tests; consists of a chem 20 and complete blood count [CBC]) analysis, and physical examination. Compliance with occlusion and capsule consumption were assessed by questionnaire and by capsule count, respectively. At the end of the dosing regimen, the levodopa/carbidopa group significantly improved in visual acuity by 2.7 lines and in mean contrast sensitivity by 72% in the amblyopic eye. The placebo group improved in visual acuity by 1.6 lines in the amblyopic eye. Tolerability and occlusion compliance were similar between groups; however, capsule ingestion compliance was significantly lower in the levodopa/carbidopa group. One month after the termination of treatment, the levodopa/carbidopa group maintained a significant 1.2-line improvement in visual acuity and 74% improvement in contrast sensitivity in the amblyopic eye. The placebo group did not maintain an improvement in visual acuity between the eyes. It is concluded that levodopa/carbidopa, at an average of 0.48/0.12 mg/kg, is well tolerated and, when combined with part-time occlusion, is efficacious in improving visual function in amblyopic children.